Maven Securities LTD Aurinia Pharmaceuticals Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$13.19 - $16.66 $659,500 - $833,000
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$14.12 - $18.33 $706,000 - $916,499
50,000 New
50,000 $813,000
Q1 2020

May 15, 2020
SELL
$11.34 - $21.46 $2.43 Million - $4.61 Million
-214,673 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$3.88 - $21.42 $832,931 - $4.6 Million
214,673 New
214,673 $4.37 Million

Others Institutions Holding AUPH

# of Institutions
207
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.28B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email